Which haematology patients are at higher risk of COVID-19?’
Watch this excellent presentation by Dr Rob Weinkove of the Malaghan Institute, courtesy of Leukaemia & Blood Cancer NZ, on ‘COVID-19 and haematology patients - protecting yourself in 2022’
https://youtu.be/wSet-9sB-VM
Launch of the Patient Impact Statement of the International COVID-19 Blood Cancer Coalition (ICBCC)
The coalition has prepared the Statement for use in different countries to aid when advocating for the provision of anti-COVID-19 treatment and care for immunocompromised or immunosuppressed (IC/IS) blood cancer patients. The Statement has been endorsed by multiple networks and national organisations of the global patient advocacy community as well as renowned medical societies and representatives from the global clinical community.